KDF Youth Highlights KDF Youth is a KD Foundation program created by youth for youth. The group was launched in September 2020 to increase Kawasaki Disease (KD) awareness among youth and teenagers. Since its inception, the group has met...
Read More
Chance’s Kawasaki Disease Story Chance was diagnosed with Kawasaki Disease when he was 3 years old. He developed a fever on May 31, 2006, and was treated for a viral infection at a local urgent care clinic. Over the...
Ask the KD Experts: Are there any updates on the safety of the COVID-19 vaccine for children and adults with a history of Kawasaki disease? New inquiries regarding updates on the safety of the COVID-19 vaccine in children and...
Over Half A Million Dollars Donated to Kawasaki Disease Research Thanks to YOU, we have contributed $532,000 to advancing KD research; most significantly, we provided a grant to the Kawasaki Disease Research Center at the University of California San Diego...
Kawasaki Disease Awareness Day is Today – Wednesday, January 26, 2022! Twelve years ago, the Kawasaki Disease Foundation requested to have January 26th designated as KD Awareness Day. Senator Jim Webb of Virginia and Daniel Inouye of Hawaii sponsored...
January 26th is National Kawasaki Disease Awareness Day Join the Kawasaki Disease Foundation in raising awareness for Kawasaki Disease from January 1st to 26th, 2022 How YOU can HELP: Be a part of the Wear Your Heart on Your...
Sudden cardiac death in adult with prior history of Kawasaki disease without coronary artery involvement: A case report Lisa Connelly was 37 when she passed away from a massive heart attack on November 29, 2015. The pathology report showed...
Watch the 2021- UCSD KD Parent Symposium (Virtual Event) Annual Kawasaki Disease Parent Symposium hosted by the University of California San Diego, Kawasaki Disease Research Center. The event was held virtually via Zoom. Video Time Stamp Speaker Topic 00:00:00...
Infliximab versus second intravenous immunoglobulin for treatment of resistant Kawasaki disease in the USA (KIDCARE): a randomised, multicentre comparative effectiveness trial Summary Background Although intravenous immunoglobulin (IVIG) is effective therapy for Kawasaki disease, 10–20% of patients have recrudescent fever...
Same Treatment Tested for Kids with Kawasaki Disease and Rare COVID-19 Reaction In a pair of new studies, published online October 26 and August 31, 2021, two collaborating teams of researchers at University of California San Diego School of...